Adding Whole Pelvic Radiation to Chemotherapy May Prolong Survival in Advanced Cervical Cancer

Share this content:
Data indicate that the addition of WPR to chemotherapy may provide a survival benefit, though prospective studies are needed to confirm these findings.
Data indicate that the addition of WPR to chemotherapy may provide a survival benefit, though prospective studies are needed to confirm these findings.

The addition of whole pelvic radiation (WPR) to chemotherapy may provide an overall survival (OS) benefit for women with stage IVB cervical cancer, according to a retrospective study presented at the 2017 Society for Gynecologic Oncology Annual Meeting.1

The multiinstitutional, retrospective review included data from 127 patients diagnosed with stage IVB cervical cancer between 2005 and 2015. The analysis included the Kaplan-Meier method for OS estimates and descriptive statistics for demographic, oncologic, and treatment factors.

The median age of the cohort was 54; 36% were Caucasian, 35% were Hispanic, and 16% were African American. Most tumors were grade 2 or 3 squamous cell carcinoma. At diagnosis, 20% of patients elected for hospice care with an OS of 2.2 months.

Of patients who received active treatment, 35% underwent WPR with chemotherapy and 65% were treated with chemotherapy alone. Patients who received WPR experienced a significantly prolonged OS of 22 months compared with 10 months when treated with chemotherapy alone (hazard ratio [HR], 0.30; P < .01).

Complication rates, including ureteral obstruction, vaginal bleeding, pelvic infection, pelvic pain, and fistula, were similar between the groups.

“There was a trend towards less frequent use of WPR with the introduction of bevacizumab. Further study is warranted to determine which subgroups may benefit the most from this novel treatment strategy,” wrote the authors.

RELATED: Cervical Cancer: SLN Biopsy Associated With Fewer Complications

These data indicate that the addition of WPR to chemotherapy may provide a survival benefit, though prospective studies are needed to confirm these findings.

Reference

  1. Perkins VB, Matsuo K, Mostofizadeh S, et al. Combining whole pelvic radation with chemotherapy in stage IVB cervical cancer: a novel treatment strategy. Paper presented at: 48th Annual Meeting of the Society of Gynecologic Oncology; March 12-15, 2017; National Harbor, MD.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs